The Board has remanded the claims for service connection for thrombocytopenia and insomnia due to incomplete service treatment records and new VA treatment records. The Veteran's contentions regarding his nosebleeds during deployment and sleep disruptions while on Quick Reaction Force (QRF) are also being addressed.
The deciding factor: The Board found that additional service treatment records were needed, as well as evidence related to the Veteran’s claims for insomnia and thrombocytopenia.
- Claimed conditions
- thrombocytopenia, insomnia
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- June 4, 2019
- Citation
- 19142787
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Partly granted
The Board granted service connection for asthma and remanded claims for insomnia and sleep apnea. Other conditions were denied.
- Denied
The Board denied service connection for insomnia as the Veteran does not have a diagnosis of chronic insomnia independent of her service-connected major depressive disorder.
- Granted
The Board granted restoration of service connection for insomnia, finding that the severance was improper.
- Denied
The Board denied the veteran's claims for an earlier effective date, service connection for bilateral hearing loss, and service connection for insomnia.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.